Therapeutic implication of HER2 in advanced biliary tract cancer

Currently, there is no validated therapeutic target for biliary tract cancer (BTC). This study aimed to investigate the pre-clinical and clinical implication of HER2 as a therapeutic target in BTC. We established two novel HER2-amplified BTC cell lines, SNU-2670 and SNU-2773, from gallbladder cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Ah-Rong, Kim, Ji-Won, Cha, Yongjun, Ha, Hyerim, Park, Ji Eun, Bang, Ju-Hee, Jin, Mei Hua, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Oh, Do-Youn, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295408/
https://www.ncbi.nlm.nih.gov/pubmed/27517322
http://dx.doi.org/10.18632/oncotarget.11157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295408/
https://www.ncbi.nlm.nih.gov/pubmed/27517322
http://dx.doi.org/10.18632/oncotarget.11157

Ejemplares similares